MA42667A - Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser - Google Patents

Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser

Info

Publication number
MA42667A
MA42667A MA042667A MA42667A MA42667A MA 42667 A MA42667 A MA 42667A MA 042667 A MA042667 A MA 042667A MA 42667 A MA42667 A MA 42667A MA 42667 A MA42667 A MA 42667A
Authority
MA
Morocco
Prior art keywords
multiplex
translation
compositions
cell
systems
Prior art date
Application number
MA042667A
Other languages
English (en)
Inventor
Nelson Barton
Ihsiung Brandon Chen
Stephanie Culler
Priti Pharkya
Dien Steve Van
Original Assignee
Genomatica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomatica Inc filed Critical Genomatica Inc
Publication of MA42667A publication Critical patent/MA42667A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA042667A 2015-08-20 2016-08-19 Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser MA42667A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562207844P 2015-08-20 2015-08-20

Publications (1)

Publication Number Publication Date
MA42667A true MA42667A (fr) 2021-05-05

Family

ID=58051779

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042667A MA42667A (fr) 2015-08-20 2016-08-19 Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser

Country Status (5)

Country Link
US (2) US20180237847A1 (fr)
EP (1) EP3337490A4 (fr)
CA (1) CA2994304A1 (fr)
MA (1) MA42667A (fr)
WO (1) WO2017031399A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3430153A1 (fr) * 2016-04-14 2019-01-23 DSM Sinochem Pharmaceuticals Netherlands B.V. Protéines type mbth dans des processus eucaryotes catalysés par nrps
IL265109B2 (en) 2016-09-13 2024-05-01 Allergan Inc Stabilized Clostridium toxin preparations without protein
US20190376069A1 (en) * 2017-02-07 2019-12-12 The Regents Of The University Of California Use of microbial consortia in the production of multi-protein complexes
CN108374028B (zh) * 2017-02-27 2021-05-11 扬州大学 一种利用化学表观遗传修饰提高海洋真菌中azaphilone类化合物产量的方法
WO2018165159A1 (fr) * 2017-03-06 2018-09-13 Synvitrobio, Inc. Procédés et systèmes de biodécouverte sans cellule de produits naturels
CN106978471A (zh) * 2017-03-27 2017-07-25 海南大学 一种酰基转移酶标记的工程化噬菌体快速检测微生物
WO2018187482A1 (fr) * 2017-04-04 2018-10-11 The Board Of Trustees Of The University Of Illinois Procédés de production de peptides lasso biologiquement actifs
KR101969506B1 (ko) * 2017-05-04 2019-08-13 주식회사 앤코스메슈 곰보버섯 추출물을 유효성분으로 포함하며 항암효능을 갖는 혼합 조성물
CN109321620A (zh) * 2017-07-31 2019-02-12 康码（上海）生物科技有限公司 一种蛋白合成冻干制剂及其制备方法和应用
CN107602609B (zh) * 2017-08-31 2020-07-21 湖南理工学院 一种以p(o)-oh化合物与含甲基取代芳香烃制备有机磷酸酯类化合物的方法
JP2021500027A (ja) * 2017-10-19 2021-01-07 シンビトロバイオ， インコーポレイテッド 嫌気性無細胞システムおよび環境、ならびにこれらを作製および使用するための方法
WO2019090205A1 (fr) 2017-11-06 2019-05-09 Snap Bio, Inc. Compositions d'inhibiteur de kinase pim, procédés et utilisations de celles-ci
GB2584211B (en) * 2017-11-16 2023-05-24 Synthex Inc Selective modulation of protein-protein interactions
WO2019127469A1 (fr) * 2017-12-29 2019-07-04 康码（上海）生物科技有限公司 Système énergétique de régénération à haut rendement (ser), kit et sa méthode de préparation
CN108192908A (zh) * 2018-01-29 2018-06-22 天津大学 利用筑波链霉菌提高他克莫司发酵产量的方法
CN108504669A (zh) * 2018-03-21 2018-09-07 天津大学 一种含小分子糖的体外高效合成蛋白质的系统
US20210024971A1 (en) * 2018-03-30 2021-01-28 Lassogen, Inc. Methods for producing, discovering, and optimizing lasso peptides
WO2019195655A1 (fr) * 2018-04-06 2019-10-10 University Of Florida Research Foundation, Incorporated Souches de streptomyces albus modifiées
CN112513251A (zh) * 2018-06-06 2021-03-16 辛格隆股份公司 改造的抗微生物肽
GB201817971D0 (en) * 2018-11-02 2018-12-19 British American Tobacco Investments Ltd Method
US10768173B1 (en) * 2019-09-06 2020-09-08 Element Biosciences, Inc. Multivalent binding composition for nucleic acid analysis
CN111778222B (zh) * 2019-04-04 2024-03-22 中国科学院微生物研究所 一个能在真菌中产生黄酮类化合物的nrps-pks杂合蛋白及其编码基因与应用
CN109988219B (zh) * 2019-04-22 2020-06-05 云南大学 一种倍半萜环己烯酮类化合物及其制备方法和应用
CN110343639B (zh) * 2019-07-23 2021-04-27 中国医药集团总公司四川抗菌素工业研究所 一株产15(s)-o-乙基雷帕霉素的链霉菌
AU2020328511A1 (en) 2019-08-09 2022-03-03 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition
US11287422B2 (en) 2019-09-23 2022-03-29 Element Biosciences, Inc. Multivalent binding composition for nucleic acid analysis
CN110643578B (zh) * 2019-10-25 2021-02-19 浙江工商大学 一株抗阿维拉霉素a单克隆抗体杂交瘤细胞株及其应用
CN110863002A (zh) * 2019-11-29 2020-03-06 武汉赛维尔生物科技有限公司 一种改造次级翻译起始位点使蛋白正确表达的方法
AU2021206616A1 (en) * 2020-01-06 2022-08-25 Lassogen, Inc. Lasso peptides for treatment of cancer
JP2023516030A (ja) * 2020-02-28 2023-04-17 シンビトロバイオ， インコーポレイテッド 無細胞系を用いて形質を特定するための方法および組成物
CN113717909A (zh) * 2020-05-26 2021-11-30 杭州中美华东制药有限公司 一种达托霉素高产菌株及其应用
CN113046380A (zh) * 2021-03-19 2021-06-29 清华大学 一种基于σ因子作为转录元件的无细胞蛋白质合成方法
CN115612718A (zh) * 2021-07-13 2023-01-17 中国科学院北京基因组研究所(国家生物信息中心) 一种单细胞翻译组测序的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480772A (en) * 1993-02-03 1996-01-02 Brandeis University In vitro activation of a nucleus
US6495348B1 (en) * 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
DK2296676T3 (en) * 2008-05-09 2016-12-19 Regenics As cellular extracts
US20130316397A1 (en) * 2012-04-30 2013-11-28 The Board Of Trustees Of The Leland Standford Junior University Cell-Free Polypeptide Synthesis

Also Published As

Publication number Publication date
WO2017031399A1 (fr) 2017-02-23
US20230399688A1 (en) 2023-12-14
EP3337490A4 (fr) 2019-07-24
CA2994304A1 (fr) 2017-02-23
US20180237847A1 (en) 2018-08-23
EP3337490A1 (fr) 2018-06-27

Similar Documents

Publication Publication Date Title
MA42667A (fr) Compositions et systèmes multiplexés pour la transcription-traduction et la synthèse protéique couplées sans cellules et procédés pour les utiliser
DK3303395T3 (da) Anti-cd40-antistoffer og anvendelser deraf
DK3307322T3 (da) Humaniserede anti-cd40-antistoffer og anvendelser deraf
IL291604A (en) Soluble pre-fusion rsv f proteins are stabilized
DK3368572T3 (da) Anti-pd-1-antistoffer og -sammensætninger
DK3273992T3 (da) Antistoffer mod ICOS
IL263223A (en) Antibodies against cd40 and their uses
BR112017021040A2 (pt) anticorpos dirigidos contra proteína mucina e imunoglobulina de célula t3 (tim-3)
EP3155018A4 (fr) Protéines de fusion à anticorps à région constante et compositions les contenant
DK3274370T3 (da) Anti-ceacam6-antistoffer og anvendelser deraf
CU20150117A7 (es) Inmunoterapia tau
EP3316909A4 (fr) Anticorps anti-ntb-a ainsi que compositions et procédés associés
EP3316861A4 (fr) Compositions et procédés d'encapsulation améliorée de protéines fonctionnelles dans des vésicules polymères
EP3529280A4 (fr) Anticorps dirigés contre les protéines mica et micb
EP3256163A4 (fr) Méthodes et compositions pour moduler les protéines lilr
EP3331563A4 (fr) Anticorps anti-cd154 et procédés d'utilisation correspondant
EP3288587A4 (fr) Modulation de réponse immunitaire au moyen d'anticorps agonistes de btla
IL297395B1 (en) btla fusion protein agonists and uses thereof
EP3313993A4 (fr) Anticorps anti-apobec3 et leurs procédés de fabrication et d'utilisation
EP3330376A4 (fr) ANTICORPS ANTI-PROTÉINE Eva1
EP3710482A4 (fr) Compositions et méthodes de fabrication et d'utilisation d'anticorps bispécifiques
DK3574100T3 (da) Cellefrit proteinsyntesesystem
EP3584254A4 (fr) Modulateur peptidique de récepteurs purinergiques
AU2017903085A0 (en) Methods of inhibiting transmembrane proteins
AU2018902889A0 (en) Methods of inhibiting transmembrane proteins